Free Trial

Korro Bio (KRRO) News Today

$51.30
+1.05 (+2.09%)
(As of 05/31/2024 ET)
Monashee Investment Management LLC Invests $4.35 Million in Korro Bio, Inc. (NASDAQ:KRRO)
Monashee Investment Management LLC purchased a new stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 90,805 shares of the company's stock, valued at appr
Atlas Venture Life Science Advisors LLC Invests $53.65 Million in Korro Bio, Inc. (NASDAQ:KRRO)
Atlas Venture Life Science Advisors LLC bought a new position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 1,119,292 shares of the company's stock, valued at approximately $
Korro Bio (NASDAQ:KRRO) Rating Reiterated by HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $100.00 price objective on shares of Korro Bio in a research note on Tuesday.
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $54.66
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $54.66
Korro Bio, Inc. (KRRO)
Korro Bio (NASDAQ:KRRO) Shares Up 5.3%
Korro Bio (NASDAQ:KRRO) Trading Up 5.3%
Brokers Issue Forecasts for Korro Bio, Inc.'s Q2 2024 Earnings (NASDAQ:KRRO)
Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Stock analysts at HC Wainwright raised their Q2 2024 EPS estimates for shares of Korro Bio in a report issued on Wednesday, May 15th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn ($2.43) per share for the quarter, up from t
Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Down 7.7% in April
Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 124,000 shares, a decline of 7.7% from the April 15th total of 134,400 shares. Approximately 2.7% of the shares of the stock are sold short. Based on an average trading volume of 34,200 shares, the short-interest ratio is presently 3.6 days.
Korro Bio (NASDAQ:KRRO) PT Lowered to $100.00 at HC Wainwright
HC Wainwright reduced their target price on Korro Bio from $115.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday.
Korro Bio (NASDAQ:KRRO) Earns "Outperform" Rating from BMO Capital Markets
BMO Capital Markets reissued an "outperform" rating and set a $120.00 price target on shares of Korro Bio in a research report on Wednesday.
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $58.53
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $58.53
Korro Bio (NASDAQ:KRRO) Shares Down 5.7%
Korro Bio (NASDAQ:KRRO) Trading Down 5.7%
Korro Bio, Inc. (NASDAQ:KRRO) Major Shareholder Buys $999,992.00 in Stock
Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Venture Opportunity Fund Atlas acquired 17,857 shares of the business's stock in a transaction on Monday, April 22nd. The shares were bought at an average cost of $56.00 per share, with a total value of $999,992.00. Following the completion of the acquisition, the insider now owns 195,074 shares of the company's stock, valued at approximately $10,924,144. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Korro Bio (NASDAQ:KRRO) Shares Down 4%
Korro Bio (NASDAQ:KRRO) Shares Down 4%
Korro Announces $70 Million Private Placement
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $73.37
Korro Bio (NASDAQ:KRRO) Shares Gap Up to $73.37
Korro Bio (NASDAQ:KRRO) Stock Price Down 3.9%
Korro Bio (NASDAQ:KRRO) Stock Price Down 3.9%
Korro Bio (NASDAQ:KRRO) Trading Up 5.2%
Korro Bio (NASDAQ:KRRO) Shares Up 5.2%
HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00
HC Wainwright raised their target price on shares of Korro Bio from $100.00 to $115.00 and gave the company a "buy" rating in a report on Thursday.
Korro Bio (NASDAQ:KRRO) Given Overweight Rating at Piper Sandler
Piper Sandler reissued an "overweight" rating and set a $180.00 price target on shares of Korro Bio in a research note on Wednesday.
Korro Bio (NASDAQ:KRRO) PT Raised to $90.00
Royal Bank of Canada lifted their price target on Korro Bio from $70.00 to $90.00 and gave the company an "outperform" rating in a report on Wednesday.
Get Korro Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter.

Do This Before July 30 2024 To Claim Trump’s Gift (Ad)

In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.

You just have to make this simple move before July 30, 2024.

KRRO Media Mentions By Week

KRRO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRRO
News Sentiment

0.65

0.76

Average
Medical
News Sentiment

KRRO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRRO Articles
This Week

4

1

KRRO Articles
Average Week

Get Korro Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:KRRO) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners